ID   ODP2_HUMAN              Reviewed;         647 AA.
AC   P10515; Q16783; Q53EP3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   10-MAY-2017, entry version 206.
DE   RecName: Full=Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial;
DE            EC=2.3.1.12;
DE   AltName: Full=70 kDa mitochondrial autoantigen of primary biliary cirrhosis;
DE            Short=PBC;
DE   AltName: Full=Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex;
DE   AltName: Full=M2 antigen complex 70 kDa subunit;
DE   AltName: Full=Pyruvate dehydrogenase complex component E2;
DE            Short=PDC-E2;
DE            Short=PDCE2;
DE   Flags: Precursor;
GN   Name=DLAT; Synonyms=DLTA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-43; ALA-318
RP   AND ASN-451.
RC   TISSUE=Kidney;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 33-647.
RC   TISSUE=Placenta;
RX   PubMed=3174635; DOI=10.1073/pnas.85.19.7317;
RA   Coppel R.L., McNeilage L.J., Surh C.D., van de Water J.,
RA   Spithill T.W., Whittingham S., Gershwin M.E.;
RT   "Primary structure of the human M2 mitochondrial autoantigen of
RT   primary biliary cirrhosis: dihydrolipoamide acetyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:7317-7321(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 73-647, AND LIPOYLATION AT LYS-132 AND
RP   LYS-259.
RC   TISSUE=Liver;
RX   PubMed=3191998; DOI=10.1016/0014-5793(88)80337-5;
RA   Thekkumkara T.J., Ho L., Wexler I.D., Pon G., Liu T., Patel M.S.;
RT   "Nucleotide sequence of a cDNA for the dihydrolipoamide
RT   acetyltransferase component of human pyruvate dehydrogenase complex.";
RL   FEBS Lett. 240:45-48(1988).
RN   [5]
RP   SUBUNIT.
RX   PubMed=14638692; DOI=10.1074/jbc.M308172200;
RA   Hiromasa Y., Fujisawa T., Aso Y., Roche T.E.;
RT   "Organization of the cores of the mammalian pyruvate dehydrogenase
RT   complex formed by E2 and E2 plus the E3-binding protein and their
RT   capacities to bind the E1 and E3 components.";
RL   J. Biol. Chem. 279:6921-6933(2004).
RN   [6]
RP   INTERACTION WITH PDHB.
RX   PubMed=20160912; DOI=10.1016/j.molcatb.2009.05.001;
RA   Patel M.S., Korotchkina L.G., Sidhu S.;
RT   "Interaction of E1 and E3 components with the core proteins of the
RT   human pyruvate dehydrogenase complex.";
RL   J. Mol. Catal., B Enzym. 61:2-6(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-466, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   INTERACTION WITH SIRT4, LIPOYLATION AT LYS-132 AND LYS-259, AND
RP   DELIPOYLATION AT LYS-132 AND LYS-259.
RX   PubMed=25525879; DOI=10.1016/j.cell.2014.11.046;
RA   Mathias R.A., Greco T.M., Oberstein A., Budayeva H.G., Chakrabarti R.,
RA   Rowland E.A., Kang Y., Shenk T., Cristea I.M.;
RT   "Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex
RT   activity.";
RL   Cell 159:1615-1625(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   STRUCTURE BY NMR OF 214-315.
RX   PubMed=9649469; DOI=10.1016/S0016-5085(98)70375-0;
RA   Howard M.J., Fuller C., Broadhurst R.W., Perham R.N., Tang J.G.,
RA   Quinn J., Diamond A.G., Yeaman S.J.;
RT   "Three-dimensional structure of the major autoantigen in primary
RT   biliary cirrhosis.";
RL   Gastroenterology 115:139-146(1998).
RN   [13]
RP   INVOLVEMENT IN PDHE2 DEFICIENCY.
RX   PubMed=16049940; DOI=10.1002/ana.20550;
RA   Head R.A., Brown R.M., Zolkipli Z., Shahdadpuri R., King M.D.,
RA   Clayton P.T., Brown G.K.;
RT   "Clinical and genetic spectrum of pyruvate dehydrogenase deficiency:
RT   dihydrolipoamide acetyltransferase (E2) deficiency.";
RL   Ann. Neurol. 58:234-241(2005).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) OF 212-319 IN COMPLEX WITH
RP   PDK3.
RX   PubMed=15861126; DOI=10.1038/sj.emboj.7600663;
RA   Kato M., Chuang J.L., Tso S.C., Wynn R.M., Chuang D.T.;
RT   "Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl
RT   domain 2 of human pyruvate dehydrogenase complex.";
RL   EMBO J. 24:1763-1774(2005).
RN   [15]
RP   STRUCTURE BY NMR OF 92-186.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RSGI RUH-058, a lipoyl domain of human 2-
RT   oxoacid dehydrogenase.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 212-319 IN COMPLEX WITH PDK3.
RX   PubMed=17532006; DOI=10.1016/j.jmb.2007.04.083;
RA   Devedjiev Y., Steussy C.N., Vassylyev D.G.;
RT   "Crystal structure of an asymmetric complex of pyruvate dehydrogenase
RT   kinase 3 with lipoyl domain 2 and its biological implications.";
RL   J. Mol. Biol. 370:407-416(2007).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 212-319 IN COMPLEX WITH PDK3.
RX   PubMed=17683942; DOI=10.1016/j.str.2007.07.001;
RA   Kato M., Li J., Chuang J.L., Chuang D.T.;
RT   "Distinct structural mechanisms for inhibition of pyruvate
RT   dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and
RT   radicicol.";
RL   Structure 15:992-1004(2007).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 214-300 IN COMPLEX WITH PDK2.
RX   PubMed=18387944; DOI=10.1074/jbc.M800311200;
RA   Green T., Grigorian A., Klyuyeva A., Tuganova A., Luo M., Popov K.M.;
RT   "Structural and functional insights into the molecular mechanisms
RT   responsible for the regulation of pyruvate dehydrogenase kinase 2.";
RL   J. Biol. Chem. 283:15789-15798(2008).
RN   [19]
RP   CRYO-ELECTRON MICROSCOPY (18.3 ANGSTROMS) OF INNER CORE OF THE
RP   COMPLEX, AND SUBUNIT.
RX   PubMed=20361979; DOI=10.1016/j.jmb.2010.03.043;
RA   Vijayakrishnan S., Kelly S.M., Gilbert R.J., Callow P., Bhella D.,
RA   Forsyth T., Lindsay J.G., Byron O.;
RT   "Solution structure and characterisation of the human pyruvate
RT   dehydrogenase complex core assembly.";
RL   J. Mol. Biol. 399:71-93(2010).
CC   -!- FUNCTION: The pyruvate dehydrogenase complex catalyzes the overall
CC       conversion of pyruvate to acetyl-CoA and CO(2), and thereby links
CC       the glycolytic pathway to the tricarboxylic cycle.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + enzyme N(6)-(dihydrolipoyl)lysine
CC       = CoA + enzyme N(6)-(S-acetyldihydrolipoyl)lysine.
CC   -!- COFACTOR:
CC       Name=(R)-lipoate; Xref=ChEBI:CHEBI:83088;
CC       Note=Binds 2 lipoyl cofactors covalently.;
CC   -!- SUBUNIT: Part of the multimeric pyruvate dehydrogenase complex
CC       that contains multiple copies of pyruvate dehydrogenase (subunits
CC       PDH1A and PDHB, E1), dihydrolipoamide acetyltransferase (DLAT, E2)
CC       and lipoamide dehydrogenase (DLD, E3) (PubMed:14638692). These
CC       subunits are bound to an inner core composed of about 48 DLAT and
CC       12 PDHX molecules (PubMed:14638692, PubMed:20361979). Interacts
CC       with PDK2 and PDK3 (PubMed:15861126, PubMed:17532006,
CC       PubMed:17683942, PubMed:18387944). Interacts with SIRT4
CC       (PubMed:25525879). Interacts with PDHB (PubMed:20160912).
CC       {ECO:0000269|PubMed:14638692, ECO:0000269|PubMed:15861126,
CC       ECO:0000269|PubMed:17532006, ECO:0000269|PubMed:17683942,
CC       ECO:0000269|PubMed:18387944, ECO:0000269|PubMed:20160912,
CC       ECO:0000269|PubMed:20361979, ECO:0000269|PubMed:25525879}.
CC   -!- INTERACTION:
CC       P11177:PDHB; NbExp=7; IntAct=EBI-2959723, EBI-1035872;
CC       Q9Y6E7:SIRT4; NbExp=6; IntAct=EBI-2959723, EBI-2606540;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- PTM: Delipoylated at Lys-132 and Lys-259 by SIRT4, delipoylation
CC       decreases the PHD complex activity. {ECO:0000269|PubMed:25525879}.
CC   -!- DISEASE: Note=Primary biliary cirrhosis is a chronic, progressive
CC       cholestatic liver disease characterized by the presence of
CC       antimitochondrial autoantibodies in patients' serum. It manifests
CC       with inflammatory obliteration of intra-hepatic bile duct, leading
CC       to liver cell damage and cirrhosis. Patients with primary biliary
CC       cirrhosis show autoantibodies against the E2 component of pyruvate
CC       dehydrogenase complex.
CC   -!- DISEASE: Pyruvate dehydrogenase E2 deficiency (PDHE2 deficiency)
CC       [MIM:245348]: Pyruvate dehydrogenase (PDH) deficiency is a major
CC       cause of primary lactic acidosis and neurological dysfunction in
CC       infancy and early childhood. In this form of PDH deficiency
CC       episodic dystonia is the major neurological manifestation, with
CC       other more common features of pyruvate dehydrogenase deficiency,
CC       such as hypotonia and ataxia, being less prominent.
CC       {ECO:0000269|PubMed:16049940}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the 2-oxoacid dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA62253.1; Type=Frameshift; Positions=449, 451, 455; Evidence={ECO:0000305};
CC       Sequence=AAA62253.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK223596; BAD97316.1; -; mRNA.
DR   EMBL; AP000907; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; J03866; AAA62253.1; ALT_SEQ; mRNA.
DR   EMBL; Y00978; CAA68787.1; -; mRNA.
DR   CCDS; CCDS8354.1; -.
DR   PIR; A40497; A40497.
DR   RefSeq; NP_001922.2; NM_001931.4.
DR   UniGene; Hs.335551; -.
DR   PDB; 1FYC; NMR; -; A=212-315.
DR   PDB; 1Y8N; X-ray; 2.60 A; B=212-319.
DR   PDB; 1Y8O; X-ray; 2.48 A; B=212-319.
DR   PDB; 1Y8P; X-ray; 2.63 A; B=212-319.
DR   PDB; 2DNE; NMR; -; A=92-186.
DR   PDB; 2PNR; X-ray; 2.50 A; C/G=212-319.
DR   PDB; 2Q8I; X-ray; 2.60 A; B=212-319.
DR   PDB; 3B8K; EM; 8.80 A; A=409-647.
DR   PDB; 3CRK; X-ray; 2.30 A; C/D=214-300.
DR   PDB; 3CRL; X-ray; 2.61 A; C/D=214-300.
DR   PDBsum; 1FYC; -.
DR   PDBsum; 1Y8N; -.
DR   PDBsum; 1Y8O; -.
DR   PDBsum; 1Y8P; -.
DR   PDBsum; 2DNE; -.
DR   PDBsum; 2PNR; -.
DR   PDBsum; 2Q8I; -.
DR   PDBsum; 3B8K; -.
DR   PDBsum; 3CRK; -.
DR   PDBsum; 3CRL; -.
DR   ProteinModelPortal; P10515; -.
DR   SMR; P10515; -.
DR   BioGrid; 108081; 41.
DR   DIP; DIP-29496N; -.
DR   IntAct; P10515; 16.
DR   MINT; MINT-3007324; -.
DR   STRING; 9606.ENSP00000280346; -.
DR   DrugBank; DB03760; Dihydrolipoic Acid.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB03758; Radicicol.
DR   iPTMnet; P10515; -.
DR   PhosphoSitePlus; P10515; -.
DR   SwissPalm; P10515; -.
DR   BioMuta; DLAT; -.
DR   DMDM; 215274207; -.
DR   EPD; P10515; -.
DR   PaxDb; P10515; -.
DR   PeptideAtlas; P10515; -.
DR   PRIDE; P10515; -.
DR   DNASU; 1737; -.
DR   Ensembl; ENST00000280346; ENSP00000280346; ENSG00000150768.
DR   GeneID; 1737; -.
DR   KEGG; hsa:1737; -.
DR   CTD; 1737; -.
DR   DisGeNET; 1737; -.
DR   GeneCards; DLAT; -.
DR   HGNC; HGNC:2896; DLAT.
DR   HPA; CAB003782; -.
DR   HPA; HPA040786; -.
DR   HPA; HPA062766; -.
DR   MalaCards; DLAT; -.
DR   MIM; 245348; phenotype.
DR   MIM; 608770; gene.
DR   neXtProt; NX_P10515; -.
DR   OpenTargets; ENSG00000150768; -.
DR   Orphanet; 79244; Pyruvate dehydrogenase E2 deficiency.
DR   PharmGKB; PA27350; -.
DR   eggNOG; KOG0557; Eukaryota.
DR   eggNOG; COG0508; LUCA.
DR   GeneTree; ENSGT00860000133743; -.
DR   HOGENOM; HOG000281566; -.
DR   HOVERGEN; HBG005063; -.
DR   InParanoid; P10515; -.
DR   KO; K00627; -.
DR   OMA; VESCIIT; -.
DR   OrthoDB; EOG091G0CAV; -.
DR   PhylomeDB; P10515; -.
DR   TreeFam; TF106145; -.
DR   BioCyc; MetaCyc:HS07688-MONOMER; -.
DR   BRENDA; 2.3.1.12; 2681.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   ChiTaRS; DLAT; human.
DR   EvolutionaryTrace; P10515; -.
DR   GeneWiki; Dihydrolipoyl_transacetylase; -.
DR   GenomeRNAi; 1737; -.
DR   PRO; PR:P10515; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000150768; -.
DR   CleanEx; HS_DLAT; -.
DR   ExpressionAtlas; P10515; baseline and differential.
DR   Genevisible; P10515; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005967; C:mitochondrial pyruvate dehydrogenase complex; NAS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0045254; C:pyruvate dehydrogenase complex; IDA:UniProtKB.
DR   GO; GO:0004742; F:dihydrolipoyllysine-residue acetyltransferase activity; IDA:MGI.
DR   GO; GO:0006086; P:acetyl-CoA biosynthetic process from pyruvate; IEA:Ensembl.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0006090; P:pyruvate metabolic process; TAS:Reactome.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome.
DR   GO; GO:0030431; P:sleep; IEA:Ensembl.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW.
DR   Gene3D; 4.10.320.10; -; 1.
DR   InterPro; IPR003016; 2-oxoA_DH_lipoyl-BS.
DR   InterPro; IPR001078; 2-oxoacid_DH_actylTfrase.
DR   InterPro; IPR000089; Biotin_lipoyl.
DR   InterPro; IPR004167; E3-bd.
DR   InterPro; IPR006257; LAT1.
DR   InterPro; IPR011053; Single_hybrid_motif.
DR   Pfam; PF00198; 2-oxoacid_dh; 1.
DR   Pfam; PF00364; Biotin_lipoyl; 2.
DR   Pfam; PF02817; E3_binding; 1.
DR   SUPFAM; SSF47005; SSF47005; 1.
DR   SUPFAM; SSF51230; SSF51230; 2.
DR   TIGRFAMs; TIGR01349; PDHac_trf_mito; 1.
DR   PROSITE; PS50968; BIOTINYL_LIPOYL; 2.
DR   PROSITE; PS00189; LIPOYL; 2.
DR   PROSITE; PS51826; PSBD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Carbohydrate metabolism;
KW   Complete proteome; Glucose metabolism; Lipoyl; Mitochondrion;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Transferase;
KW   Transit peptide; Tricarboxylic acid cycle.
FT   TRANSIT       1     86       Mitochondrion.
FT   CHAIN        87    647       Dihydrolipoyllysine-residue
FT                                acetyltransferase component of pyruvate
FT                                dehydrogenase complex, mitochondrial.
FT                                /FTId=PRO_0000020479.
FT   DOMAIN       91    167       Lipoyl-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01066}.
FT   DOMAIN      218    294       Lipoyl-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01066}.
FT   DOMAIN      356    393       Peripheral subunit-binding (PSBD).
FT                                {ECO:0000255|PROSITE-ProRule:PRU01170}.
FT   REGION      417    647       Catalytic. {ECO:0000250}.
FT   ACT_SITE    620    620       {ECO:0000255}.
FT   ACT_SITE    624    624       {ECO:0000255}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     132    132       N6-lipoyllysine. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01066,
FT                                ECO:0000269|PubMed:25525879,
FT                                ECO:0000269|PubMed:3191998}.
FT   MOD_RES     259    259       N6-lipoyllysine. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01066,
FT                                ECO:0000269|PubMed:25525879,
FT                                ECO:0000269|PubMed:3191998}.
FT   MOD_RES     466    466       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     473    473       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMF4}.
FT   MOD_RES     547    547       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMF4}.
FT   VARIANT      43     43       A -> V (in dbSNP:rs2303436).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_047410.
FT   VARIANT      98     98       S -> F (in dbSNP:rs537057).
FT                                /FTId=VAR_047411.
FT   VARIANT      99     99       L -> F (in dbSNP:rs537060).
FT                                /FTId=VAR_047412.
FT   VARIANT     209    209       Q -> R (in dbSNP:rs11553595).
FT                                /FTId=VAR_047413.
FT   VARIANT     313    313       D -> V (in dbSNP:rs11553592).
FT                                /FTId=VAR_047414.
FT   VARIANT     318    318       V -> A (in dbSNP:rs627441).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_047415.
FT   VARIANT     451    451       D -> N (in dbSNP:rs10891314).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_047416.
FT   CONFLICT    112    112       E -> K (in Ref. 4; CAA68787).
FT                                {ECO:0000305}.
FT   CONFLICT    342    342       A -> T (in Ref. 3; AAA62253).
FT                                {ECO:0000305}.
FT   CONFLICT    358    358       S -> D (in Ref. 3; AAA62253).
FT                                {ECO:0000305}.
FT   STRAND       92     95       {ECO:0000244|PDB:2DNE}.
FT   STRAND      100    102       {ECO:0000244|PDB:2DNE}.
FT   STRAND      105    110       {ECO:0000244|PDB:2DNE}.
FT   STRAND      123    129       {ECO:0000244|PDB:2DNE}.
FT   STRAND      134    138       {ECO:0000244|PDB:2DNE}.
FT   STRAND      140    147       {ECO:0000244|PDB:2DNE}.
FT   STRAND      156    158       {ECO:0000244|PDB:2DNE}.
FT   STRAND      162    168       {ECO:0000244|PDB:2DNE}.
FT   HELIX       170    177       {ECO:0000244|PDB:2DNE}.
FT   STRAND      181    183       {ECO:0000244|PDB:2DNE}.
FT   STRAND      218    222       {ECO:0000244|PDB:3CRK}.
FT   STRAND      229    231       {ECO:0000244|PDB:1FYC}.
FT   STRAND      232    238       {ECO:0000244|PDB:3CRK}.
FT   STRAND      251    256       {ECO:0000244|PDB:3CRK}.
FT   STRAND      261    265       {ECO:0000244|PDB:3CRK}.
FT   STRAND      270    277       {ECO:0000244|PDB:3CRK}.
FT   STRAND      283    285       {ECO:0000244|PDB:1Y8O}.
FT   STRAND      289    297       {ECO:0000244|PDB:3CRK}.
FT   HELIX       301    303       {ECO:0000244|PDB:2Q8I}.
SQ   SEQUENCE   647 AA;  68997 MW;  DD93A8E666E377C2 CRC64;
     MWRVCARRAQ NVAPWAGLEA RWTALQEVPG TPRVTSRSGP APARRNSVTT GYGGVRALCG
     WTPSSGATPR NRLLLQLLGS PGRRYYSLPP HQKVPLPSLS PTMQAGTIAR WEKKEGDKIN
     EGDLIAEVET DKATVGFESL EECYMAKILV AEGTRDVPIG AIICITVGKP EDIEAFKNYT
     LDSSAAPTPQ AAPAPTPAAT ASPPTPSAQA PGSSYPPHMQ VLLPALSPTM TMGTVQRWEK
     KVGEKLSEGD LLAEIETDKA TIGFEVQEEG YLAKILVPEG TRDVPLGTPL CIIVEKEADI
     SAFADYRPTE VTDLKPQVPP PTPPPVAAVP PTPQPLAPTP SAPCPATPAG PKGRVFVSPL
     AKKLAVEKGI DLTQVKGTGP DGRITKKDID SFVPSKVAPA PAAVVPPTGP GMAPVPTGVF
     TDIPISNIRR VIAQRLMQSK QTIPHYYLSI DVNMGEVLLV RKELNKILEG RSKISVNDFI
     IKASALACLK VPEANSSWMD TVIRQNHVVD VSVAVSTPAG LITPIVFNAH IKGVETIAND
     VVSLATKARE GKLQPHEFQG GTFTISNLGM FGIKNFSAII NPPQACILAI GASEDKLVPA
     DNEKGFDVAS MMSVTLSCDH RVVDGAVGAQ WLAEFRKYLE KPITMLL
//
